Company intelligence / Profile preview
Kenvue
- Ownership
- Public · KVUE
- Employees
- ~20000
- Development stage
- Commercial
Overview
Kenvue commercializes a broad portfolio of iconic over-the-counter medicines and personal care brands. Its products are widely used globally with established safety and efficacy profiles. Recent clinical studies have supported the effectiveness of key brands such as Listerine for oral health.
- Therapeutic areas
- ImmunologyOtherDermatologyGastroenterologyNeurology
- Modalities
- Small molecule (e.g., acetaminophen in Tylenol)Device (e.g., BAND-AID bandages)Protein (e.g., lactase enzyme in Lactaid)Combination product/OTC formulation
- Industry
- Pharma
Drug pipeline
19 assets18 more assets in the full pipeline.
Partnerships
Financials
- Market cap
- $37.1B
- Total revenue
- $15.1B
- Enterprise value
- $44.4B
Beyond the preview
Go deeper on Kenvue.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kenvue.